✦ LIBER ✦

Insulin glargine in type 2 diabetes in everyday clinical practice: 7 years experience

✍ Scribed by S. A. Schreiber

Book ID: 109044616
Publisher: John Wiley and Sons
Year: 2008
Tongue: English
Weight: 342 KB
Volume: 10
Category: Article
ISSN: 1462-8902
DOI: 10.1111/j.1463-1326.2008.00842.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Insulin detemir weighs in against insuli

Insulin detemir weighs in against insulin glargine in type 2 diabetes

📂 Article 📅 2006 🏛 Adis International Limited (now part of Wolters Kl ⚖ 120 KB

Outcomes with insulin glargine in patien

Outcomes with insulin glargine in patients with type 2 diabetes previously on NPH insulin: evidence from clinical practice in Spain

✍ E. Delgado; on behalf of LAUREL Spain study investigators 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 204 KB

Basal insulin glargine vs prandial insul

Basal insulin glargine vs prandial insulin lispro in type 2 diabetes

✍ Michael Roden 📂 Article 📅 2008 🏛 The Lancet 🌐 English ⚖ 41 KB

Basal insulin glargine vs prandial insul

Basal insulin glargine vs prandial insulin lispro in type 2 diabetes

✍ Sabine Arnolds; Klaus Rave 📂 Article 📅 2008 🏛 The Lancet 🌐 English ⚖ 64 KB

Basal insulin glargine vs prandial insul

Basal insulin glargine vs prandial insulin lispro in type 2 diabetes

✍ Juliana Helena Oliveira; Cristof Kazda; Alexander Simpson; Jeffrery A Jackson; R 📂 Article 📅 2008 🏛 The Lancet 🌐 English ⚖ 48 KB

Insulin glargine and receptor-mediated s

Insulin glargine and receptor-mediated signalling: clinical implications in treating type 2 diabetes

✍ Derek Le Roith 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 226 KB

## Abstract Most patients with type 2 diabetes mellitus will eventually require insulin therapy to achieve or maintain adequate glycaemic control. The introduction of insulin analogues, with pharmacokinetics that more closely mimic endogenous insulin secretion, has made physiologic insulin replacem